FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205272657> ?p ?o ?g. }

• W3205272657 endingPage "e0554" @default.
• W3205272657 startingPage "e0554" @default.
• W3205272657 abstract "Clinically deployable methods for the rapid and accurate prediction of sepsis severity that could elicit a meaningful change in clinical practice are currently lacking. We evaluated a whole-blood, multiplex host-messenger RNA expression metric, Inflammatix-Severity-2, for identifying septic, hospitalized patients' likelihood of 30-day mortality, development of chronic critical illness, discharge disposition, and/or secondary infections.Retrospective, validation cohort analysis.Single, academic health center ICU.Three hundred thirty-five critically ill adult surgical patients with sepsis.None.Whole blood was collected in PAXgene Blood RNA collection tubes at 24 hours after sepsis diagnosis and analyzed using a custom 29-messenger RNA classifier (Inflammatix-Severity-2) in a Clinical Laboratory Improvement Amendments certified diagnostic laboratory using the NanoString FLEX platform. Among patients meeting Sepsis-3 criteria, the Inflammatix-Severity-2 severity score was significantly better (p < 0.05) at predicting secondary infections (area under the receiver operating curve 0.71) and adverse clinical outcomes (area under the receiver operating curve 0.75) than C-reactive protein, absolute lymphocyte counts, total WBC count, age, and Charlson comorbidity index (and better, albeit nonsignificantly, than interleukin-6 and Acute Physiology and Chronic Health Evaluation II). Using multivariate logistic regression analysis, only combining the Charlson comorbidity index (area under the receiver operating curve 0.80) or Acute Physiology and Chronic Health Evaluation II (area under the receiver operating curve 0.81) with Inflammatix-Severity-2 significantly improved prediction of adverse clinical outcomes, and combining with the Charlson comorbidity index for predicting 30-day mortality (area under the receiver operating curve 0.79).The Inflammatix-Severity-2 severity score was superior at predicting secondary infections and overall adverse clinical outcomes compared with other common metrics. Combining a rapidly measured transcriptomic metric with clinical or physiologic indices offers the potential to optimize risk-based resource utilization and patient management adjustments that may improve outcomes in surgical sepsis. Hospitalized patients who are septic and present with an elevated IMX-SEV2 severity score and preexisting comorbidities may be ideal candidates for clinical interventions aimed at reducing the risk of secondary infections and adverse clinical outcomes." @default.
• W3205272657 created "2021-10-25" @default.
• W3205272657 creator A5002409503 @default.
• W3205272657 creator A5007397401 @default.
• W3205272657 creator A5008141025 @default.
• W3205272657 creator A5013215682 @default.
• W3205272657 creator A5031214939 @default.
• W3205272657 creator A5033552715 @default.
• W3205272657 creator A5041015920 @default.
• W3205272657 creator A5051195358 @default.
• W3205272657 creator A5058341211 @default.
• W3205272657 creator A5064071611 @default.
• W3205272657 creator A5090126800 @default.
• W3205272657 date "2021-10-01" @default.
• W3205272657 modified "2023-10-07" @default.
• W3205272657 title "A Transcriptomic Severity Metric That Predicts Clinical Outcomes in Critically Ill Surgical Sepsis Patients" @default.
• W3205272657 cites W2021632178 @default.
• W3205272657 cites W2074847887 @default.
• W3205272657 cites W2087203965 @default.
• W3205272657 cites W2101082552 @default.
• W3205272657 cites W2103645914 @default.
• W3205272657 cites W2171144560 @default.
• W3205272657 cites W2280404143 @default.
• W3205272657 cites W2282181907 @default.
• W3205272657 cites W2599245417 @default.
• W3205272657 cites W2741510240 @default.
• W3205272657 cites W2774937159 @default.
• W3205272657 cites W2792583887 @default.
• W3205272657 cites W2800030655 @default.
• W3205272657 cites W2888782727 @default.
• W3205272657 cites W2939032636 @default.
• W3205272657 cites W2943203566 @default.
• W3205272657 cites W2944935359 @default.
• W3205272657 cites W2965650449 @default.
• W3205272657 cites W2965857027 @default.
• W3205272657 cites W3000495651 @default.
• W3205272657 cites W3005797804 @default.
• W3205272657 cites W3010267838 @default.
• W3205272657 cites W3023920414 @default.
• W3205272657 cites W3026018534 @default.
• W3205272657 cites W3037549222 @default.
• W3205272657 cites W3110590387 @default.
• W3205272657 cites W3112742922 @default.
• W3205272657 cites W3119231231 @default.
• W3205272657 cites W3173831315 @default.
• W3205272657 doi "https://doi.org/10.1097/cce.0000000000000554" @default.
• W3205272657 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8522866" @default.
• W3205272657 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34671746" @default.
• W3205272657 hasPublicationYear "2021" @default.
• W3205272657 type Work @default.
• W3205272657 sameAs 3205272657 @default.
• W3205272657 citedByCount "17" @default.
• W3205272657 countsByYear W32052726572022 @default.
• W3205272657 countsByYear W32052726572023 @default.
• W3205272657 crossrefType "journal-article" @default.
• W3205272657 hasAuthorship W3205272657A5002409503 @default.
• W3205272657 hasAuthorship W3205272657A5007397401 @default.
• W3205272657 hasAuthorship W3205272657A5008141025 @default.
• W3205272657 hasAuthorship W3205272657A5013215682 @default.
• W3205272657 hasAuthorship W3205272657A5031214939 @default.
• W3205272657 hasAuthorship W3205272657A5033552715 @default.
• W3205272657 hasAuthorship W3205272657A5041015920 @default.
• W3205272657 hasAuthorship W3205272657A5051195358 @default.
• W3205272657 hasAuthorship W3205272657A5058341211 @default.
• W3205272657 hasAuthorship W3205272657A5064071611 @default.
• W3205272657 hasAuthorship W3205272657A5090126800 @default.
• W3205272657 hasBestOaLocation W32052726571 @default.
• W3205272657 hasConcept C10936531 @default.
• W3205272657 hasConcept C126322002 @default.
• W3205272657 hasConcept C151956035 @default.
• W3205272657 hasConcept C167135981 @default.
• W3205272657 hasConcept C177713679 @default.
• W3205272657 hasConcept C194828623 @default.
• W3205272657 hasConcept C2776376669 @default.
• W3205272657 hasConcept C2778384902 @default.
• W3205272657 hasConcept C2779159551 @default.
• W3205272657 hasConcept C2780347030 @default.
• W3205272657 hasConcept C30036603 @default.
• W3205272657 hasConcept C3019063607 @default.
• W3205272657 hasConcept C58471807 @default.
• W3205272657 hasConcept C71924100 @default.
• W3205272657 hasConcept C76318530 @default.
• W3205272657 hasConceptScore W3205272657C10936531 @default.
• W3205272657 hasConceptScore W3205272657C126322002 @default.
• W3205272657 hasConceptScore W3205272657C151956035 @default.
• W3205272657 hasConceptScore W3205272657C167135981 @default.
• W3205272657 hasConceptScore W3205272657C177713679 @default.
• W3205272657 hasConceptScore W3205272657C194828623 @default.
• W3205272657 hasConceptScore W3205272657C2776376669 @default.
• W3205272657 hasConceptScore W3205272657C2778384902 @default.
• W3205272657 hasConceptScore W3205272657C2779159551 @default.
• W3205272657 hasConceptScore W3205272657C2780347030 @default.
• W3205272657 hasConceptScore W3205272657C30036603 @default.
• W3205272657 hasConceptScore W3205272657C3019063607 @default.
• W3205272657 hasConceptScore W3205272657C58471807 @default.
• W3205272657 hasConceptScore W3205272657C71924100 @default.
• W3205272657 hasConceptScore W3205272657C76318530 @default.
• W3205272657 hasIssue "10" @default.

• next